XML 59 R47.htm IDEA: XBRL DOCUMENT v3.4.0.3
Collaborative Agreements (Details) - Collaborative Arrangement, Product [Member]
$ in Thousands
1 Months Ended 3 Months Ended
Aug. 07, 2015
USD ($)
product
Nov. 14, 2014
Apr. 30, 2015
USD ($)
Sep. 30, 2013
USD ($)
Mar. 31, 2016
USD ($)
Mar. 31, 2015
USD ($)
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]            
Upfront payment received       $ 10,000    
INO-3112 [Member]            
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]            
Revenue recognized $ 15,000          
License To Research Collaboration Products [Member] | Nonsoftware License Arrangement [Member]            
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]            
Deferred revenue, additions 12,500          
INO 5150 [Member]            
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]            
Revenue recognized       5,000    
INO 1800 [Member]            
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]            
Revenue recognized       3,400    
Option Right [Member] | Nonsoftware License Arrangement [Member]            
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]            
Deferred revenue, additions       1,500    
Joint Steering Committee Obligation [Member] | Nonsoftware License Arrangement [Member]            
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]            
Deferred revenue, additions       155    
MedImmune [Member]            
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]            
Upfront payment received 27,500          
Anticipated development and regulatory event based payment receivable milestones $ 700,000          
Number of additional products to be developed | product 2          
Revenue under collaborative research and development arrangements         $ 390  
Deferred revenue         13,100  
Accounts receivable         829  
Hoffman-La Roche [Member]            
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]            
Upfront payment received       10,000    
Anticipated development and regulatory event based payment receivable milestones       $ 3,000    
Revenue under collaborative research and development arrangements           $ 3,000
Deferred revenue         23  
Accounts receivable         2,400  
Length of period after date of product first commercial sale to determine agreement in effect terms       10 years    
Previously deferred revenue recognized         1,400 $ 4,200
Hoffman-La Roche [Member] | INO 5150 [Member]            
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]            
Days subsequent to termination notice effective   90 days        
Defense Advanced Research Projects Agency (DARPA) [Member]            
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]            
Deferred revenue         290  
Accounts receivable         6,300  
Term     2 years      
Base award     $ 19,600      
Option award     24,600      
Second option award     $ 11,100      
Previously deferred revenue recognized         $ 4,600